| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9940996 | American Journal of Hypertension | 2005 | 7 Pages |
Abstract
In mild-to-moderate hypertension, nebivolol and telmisartan are equally effective in reducing BP and increasing mFS. There may be differences between nebivolol and telmisartan regarding the mechanism of increase in mFS.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Katerina Fountoulaki, Vasilis Dimopoulos, John Giannakoulis, Elias Zintzaras, Filippos Triposkiadis,